Literature DB >> 26844738

Managing Epilepsy in Women.

Elizabeth E Gerard, Kimford J Meador.   

Abstract

PURPOSE OF REVIEW: Caring for a woman with epilepsy requires familiarity with the implications of antiepileptic drugs (AEDs) for pregnancy and contraception as well as an understanding of the effects of female hormones on epilepsy. RECENT
FINDINGS: AED pregnancy registries and prospective studies of cognitive development continue to confirm that valproate poses a significantly increased risk of structural and cognitive teratogenesis. In contrast, data thus far suggest that lamotrigine and levetiracetam are associated with a relatively low risk for both anatomic and developmental adverse effects, although further studies are needed for these and other AEDs. The intrauterine device is a good contraceptive option for many women with epilepsy as it is highly effective and not subject to the drug-drug interactions seen between hormonal contraception and many AEDs. Hormonal-sensitive seizures are common among women with epilepsy; however, highly effective treatments for refractory catamenial seizures are limited.
SUMMARY: Women with epilepsy should be counseled early and regularly about reproductive health as it relates to epilepsy. AED selection for women of childbearing age should take future pregnancies and contraceptive needs into consideration.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26844738      PMCID: PMC8734579          DOI: 10.1212/CON.0000000000000270

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  74 in total

1.  The teratogenicity of the newer antiepileptic drugs - an update.

Authors:  F J E Vajda; T J O'Brien; C M Lander; J Graham; M J Eadie
Journal:  Acta Neurol Scand       Date:  2014-07-18       Impact factor: 3.209

Review 2.  The impact of seizures on pregnancy and delivery.

Authors:  Line Sveberg; Sigrid Svalheim; Erik Taubøll
Journal:  Seizure       Date:  2015-02-21       Impact factor: 3.184

3.  Depression and anxiety in women with epilepsy during pregnancy and after delivery: a prospective population-based cohort study on frequency, risk factors, medication, and prognosis.

Authors:  Marte Helene Bjørk; Gyri Veiby; Simone C Reiter; Jan Øystein Berle; Anne Kjersti Daltveit; Olav Spigset; Bernt A Engelsen; Nils Erik Gilhus
Journal:  Epilepsia       Date:  2014-12-19       Impact factor: 5.864

4.  Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate.

Authors:  Erja Kaaja; Risto Kaaja; Riitta Matila; Vilho Hiilesmaa
Journal:  Neurology       Date:  2002-02-26       Impact factor: 9.910

5.  Newer-generation antiepileptic drugs and the risk of major birth defects.

Authors:  Ditte Mølgaard-Nielsen; Anders Hviid
Journal:  JAMA       Date:  2011-05-18       Impact factor: 56.272

6.  Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry.

Authors: 
Journal:  Neurology       Date:  2005-12-28       Impact factor: 9.910

7.  Seizure deterioration in women treated with oxcarbazepine during pregnancy.

Authors:  Vaiva Petrenaite; Anne Sabers; Jacob Hansen-Schwartz
Journal:  Epilepsy Res       Date:  2009-02-23       Impact factor: 3.045

8.  Treatment of seizures with medroxyprogesterone acetate: preliminary report.

Authors:  R H Mattson; J A Cramer; B V Caldwell; B C Siconolfi
Journal:  Neurology       Date:  1984-09       Impact factor: 9.910

9.  Early child development and exposure to antiepileptic drugs prenatally and through breastfeeding: a prospective cohort study on children of women with epilepsy.

Authors:  Gyri Veiby; Bernt A Engelsen; Nils Erik Gilhus
Journal:  JAMA Neurol       Date:  2013-11       Impact factor: 18.302

10.  Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers.

Authors:  Ellen Mawhinney; John Craig; Jim Morrow; Aline Russell; W Henry Smithson; Linda Parsons; Patrick J Morrison; Brenda Liggan; Beth Irwin; Norman Delanty; Stephen J Hunt
Journal:  Neurology       Date:  2013-01-09       Impact factor: 9.910

View more
  11 in total

Review 1.  Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential.

Authors:  Anna Serafini; Elizabeth Gerard; Pierre Genton; Arielle Crespel; Philippe Gelisse
Journal:  CNS Drugs       Date:  2019-03       Impact factor: 5.749

2.  Women with epilepsy.

Authors:  A Sharma; F Boller; M Koubeissi
Journal:  Funct Neurol       Date:  2016 Jul-Sep

3.  Effects of lacosamide "a novel antiepileptic drug" in the early stages of chicken embryo development.

Authors:  Mesut Mete; Beyhan Gurcu; Fatih Collu; Ulkun Unlu Unsal; Yusuf Kurtulus Duransoy; Mehmet Ibrahim Tuglu; Mehmet Selcuki
Journal:  Childs Nerv Syst       Date:  2016-07-29       Impact factor: 1.475

4.  Is neurostimulation through the vagal nerve safe during pregnancy?

Authors:  P Emanuela Voinescu; Kimford J Meador
Journal:  Epilepsy Res       Date:  2017-11       Impact factor: 3.045

Review 5.  Epilepsy during pregnancy: focus on management strategies.

Authors:  Laura M Borgelt; Felecia M Hart; Jacquelyn L Bainbridge
Journal:  Int J Womens Health       Date:  2016-09-19

6.  Verbal abilities in children of mothers with epilepsy: Association to maternal folate status.

Authors:  Elisabeth Synnøve Nilsen Husebye; Nils Erik Gilhus; Bettina Riedel; Olav Spigset; Anne Kjersti Daltveit; Marte Helene Bjørk
Journal:  Neurology       Date:  2018-08-01       Impact factor: 9.910

Review 7.  Comprehensive management of epilepsy in onchocerciasis-endemic areas: lessons learnt from community-based surveys.

Authors:  Joseph Nelson Siewe Fodjo; Marieke C J Dekker; Richard Idro; Michel Ndahura Mandro; Pierre-Marie Preux; Alfred K Njamnshi; Robert Colebunders
Journal:  Infect Dis Poverty       Date:  2019-02-10       Impact factor: 4.520

8.  Pregnancy and multiple sclerosis: Risk of unplanned pregnancy and drug exposure in utero.

Authors:  Andrew L Smith; Jeffrey A Cohen; Daniel Ontaneda; Mary Rensel
Journal:  Mult Scler J Exp Transl Clin       Date:  2019-12-12

9.  Maternal complications in pregnancy and childbirth for women with epilepsy: Time trends in a nationwide cohort.

Authors:  Kim Christian Danielsson; Nils Erik Gilhus; Ingrid Borthen; Rolv Terje Lie; Nils-Halvdan Morken
Journal:  PLoS One       Date:  2019-11-25       Impact factor: 3.240

10.  Hypertensive pregnancy complications in women with epilepsy and antiepileptic drugs: a population-based cohort study of first pregnancies in Norway.

Authors:  Kim Christian Danielsson; Ingrid Borthen; Nils-Halvdan Morken; Nils Erik Gilhus
Journal:  BMJ Open       Date:  2018-04-24       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.